1
The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
Condition(s):Chronic Kidney DiseaseLast Updated:May 21, 2013Completed
Paricalcitol: 118 Clinical Trials, Page 1 of 12
Hide Studies Not Open or Pending
2
Intravenous Paricalcitol in Chronic Hemodialysis Patients
Condition(s):Endstage Renal Disease; Secondary HyperparathyroidismLast Updated:January 18, 2017Unknown status
3
Effect of Paricalcitol Over Vessel Wall
Condition(s):NephropathyLast Updated:February 26, 2015Terminated
4
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Condition(s):Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism (SHPT)Last Updated:May 1, 2020Recruiting
5
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Condition(s):End-Stage Renal Disease; Secondary HyperparathyroidismLast Updated:July 2, 2018Completed
6
Paricalcitol Effect on Anemia in CKD
Condition(s):Anemia; Chronic Kidney DiseaseLast Updated:July 30, 2014Completed
7
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Condition(s):Chronic Kidney Disease (CKD) Stage 5; Hypertrophy, Left VentricularLast Updated:January 20, 2012Terminated
8
Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions
Condition(s):HealthyLast Updated:December 23, 2014Completed
9
Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
Condition(s):Chronic Kidney Disease Stage 3 and 4Last Updated:July 2, 2018Completed
10
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
Condition(s):Chronic Kidney Disease; Endothelial Dysfunction; Inflammation; HypertensionLast Updated:June 3, 2009Completed